The phytoestrogen, quercetin, in serum, uterus and ovary as a potential treatment for dehydroepiandrosterone-induced polycystic ovary syndrome in the rat

References

Ademoglu, E. N., Gorar, S., Carlıoglu, A., Dellal, F. D., Berberoglu, Z., Akdeniz, D., Uysal, S., and Karakurt, F. (2014). Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome. J. Endocrinol. Invest. 37, 715–719.
| Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome.Crossref | GoogleScholarGoogle Scholar | 24920281PubMed |

Ardawi, M. S. M., and Rouzi, A. A. (2005). Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil. Steril. 83, 1708–1716.
| Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.Crossref | GoogleScholarGoogle Scholar |

Barber, T. M., Dimitriadis, G. K., Andreou, A., and Franks, S. (2016). Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin. Med. (Lond.) 16, 262–266.
| Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance.Crossref | GoogleScholarGoogle Scholar | 27251917PubMed |

Begum, M. R., Ferdous, J., Begum, A., and Quadir, E. (2009). Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertil. Steril. 92, 853–857.
| Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.Crossref | GoogleScholarGoogle Scholar | 18177867PubMed |

Bergh, C., Carlsson, B., Olsson, J.-H., Selleskog, U., and Hillensjö, T. (1993). Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil. Steril. 59, 323–331.
| Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin.Crossref | GoogleScholarGoogle Scholar | 8425626PubMed |

Bulun, S. E., Imir, G., Utsunomiya, H., Thung, S., Gurates, B., Tamura, M., and Lin, Z. (2005). Aromatase in endometriosis and uterine leiomyomata. J. Steroid Biochem. Mol. Biol. 95, 57–62.
| Aromatase in endometriosis and uterine leiomyomata.Crossref | GoogleScholarGoogle Scholar | 16024248PubMed |

Caldwell, L. K., Pierce, A. L., Riley, L. G., Duncan, C. A., and Nagler, J. J. (2014). Plasma nesfatin-1 is not affected by long-term food restriction and does not predict rematuration among iteroparous female rainbow trout (Oncorhynchus mykiss). PLoS One 9, e85700.
| Plasma nesfatin-1 is not affected by long-term food restriction and does not predict rematuration among iteroparous female rainbow trout (Oncorhynchus mykiss).Crossref | GoogleScholarGoogle Scholar | 24416444PubMed |

Campbell, D. R., and Kurzer, M. S. (1993). Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J. Steroid Biochem. Mol. Biol. 46, 381–388.
| Flavonoid inhibition of aromatase enzyme activity in human preadipocytes.Crossref | GoogleScholarGoogle Scholar | 9831487PubMed |

Cao, Y., Zhuang, M.-f., Yang, Y., Xie, S.-w., Cui, J.-g., Cao, L., Zhang, T.-t., and Zhu, Y. (2014). Preliminary study of quercetin affecting the hypothalamic-pituitary-gonadal axis on rat endometriosis model. Evid. Based Complement. Alternat. Med. 2014, 781684.
| Preliminary study of quercetin affecting the hypothalamic-pituitary-gonadal axis on rat endometriosis model.Crossref | GoogleScholarGoogle Scholar | 25530789PubMed |

Carmina, E., and Lobo, R. A. (1999). Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J. Clin. Endocrinol. Metab. 84, 1897–1899.
| Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women.Crossref | GoogleScholarGoogle Scholar | 10372683PubMed |

Carmina, E., Fruzzetti, F., and Lobo, R. A. (2018). Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function. Gynecol. Endocrinol. 34, 301–304.
| Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function.Crossref | GoogleScholarGoogle Scholar | 29073797PubMed |

Chen, Y.-C., Nagpal, M. L., Stocco, D. M., and Lin, T. (2007). Effects of genistein, resveratrol, and quercetin on steroidogenesis and proliferation of MA-10 mouse Leydig tumor cells. J. Endocrinol. 192, 527–537.
| Effects of genistein, resveratrol, and quercetin on steroidogenesis and proliferation of MA-10 mouse Leydig tumor cells.Crossref | GoogleScholarGoogle Scholar | 17332522PubMed |

Chen, J., Shen, S., Tan, Y., Xia, D., Xia, Y., Cao, Y., Wang, W., Wu, X., Wang, H., and Yi, L. (2015). The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome. J. Ovarian Res. 8, 11.
| The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome.Crossref | GoogleScholarGoogle Scholar | 25881575PubMed |

Comim, F. V., Hardy, K., and Franks, S. (2013). Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. PLoS One 8, e80416.
| Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome.Crossref | GoogleScholarGoogle Scholar | 24260388PubMed |

Dubey, R. K., Gillespie, D. G., Zacharia, L. C., Rosselli, M., Korzekwa, K. R., Fingerle, J., and Jackson, E. K. (2000). Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms. Biochem. Biophys. Res. Commun. 278, 27–33.
| Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms.Crossref | GoogleScholarGoogle Scholar | 11071850PubMed |

Eagleson, C. A., Gingrich, M. B., Pastor, C. L., Arora, T. K., Burt, C. M., Evans, W. S., and Marshall, J. C. (2000). Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J. Clin. Endocrinol. Metab. 85, 4047–4052.
| 11095431PubMed |

Eriksen, M. B., Glintborg, D., Nielsen, M. F. B., Jakobsen, M. A., Brusgaard, K., Tan, Q., and Gaster, M. (2014). Testosterone treatment increases androgen receptor and aromatase gene expression in myotubes from patients with PCOS and controls, but does not induce insulin resistance. Biochem. Biophys. Res. Commun. 451, 622–626.
| Testosterone treatment increases androgen receptor and aromatase gene expression in myotubes from patients with PCOS and controls, but does not induce insulin resistance.Crossref | GoogleScholarGoogle Scholar | 25130462PubMed |

Formica, J. V., and Regelson, W. (1995). Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 33, 1061–1080.
| Review of the biology of quercetin and related bioflavonoids.Crossref | GoogleScholarGoogle Scholar | 8847003PubMed |

Giudice, L. C. (2006). Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract. Res. Clin. Endocrinol. Metab. 20, 235–244.
| Endometrium in PCOS: implantation and predisposition to endocrine CA.Crossref | GoogleScholarGoogle Scholar | 16772154PubMed |

Henmi, H., Endo, T., Nagasawa, K., Hayashi, T., Chida, M., Akutagawa, N., Iwasaki, M., Kitajima, Y., Kiya, T., Nishikawa, A., Manase, K., and Kudo, R. (2001). Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biol. Reprod. 64, 157–162.
| Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats.Crossref | GoogleScholarGoogle Scholar | 11133670PubMed |

Honnma, H., Endo, T., Henmi, H., Nagasawa, K., Baba, T., Yamazaki, K., Kitajima, Y., Hayashi, T., Manase, K., and Saito, T. (2006). Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats. Apoptosis 11, 1525–1533.
| Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats.Crossref | GoogleScholarGoogle Scholar | 16820958PubMed |

Jakimiuk, A. J., Weitsman, S. R., Brzechffa, P. R., and Magoffin, D. A. (1998). Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol. Hum. Reprod. 4, 1–8.
| Aromatase mRNA expression in individual follicles from polycystic ovaries.Crossref | GoogleScholarGoogle Scholar | 9510005PubMed |

Jungbauer, A., and Medjakovic, S. (2014). Phytoestrogens and the metabolic syndrome. J. Steroid Biochem. Mol. Biol. 139, 277–289.
| Phytoestrogens and the metabolic syndrome.Crossref | GoogleScholarGoogle Scholar | 23318879PubMed |

Kafali, H., Iriadam, M., Ozardalı, I., and Demir, N. (2004). Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch. Med. Res. 35, 103–108.
| Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease.Crossref | GoogleScholarGoogle Scholar | 15010188PubMed |

Kavitha, A., Narendra, B., Sathish, K., and Veena, K. (2016). Evaluation of effects of Commiphora Wightii in dehydroepiandrosterone (DHEA) induced polycystic ovary syndrome (PCOS) in rats. PharmaTutor 4, 47–55.

Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 8, 3–63.
| Pharmacology of estrogens and progestogens: influence of different routes of administration.Crossref | GoogleScholarGoogle Scholar | 16112947PubMed |

Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., Van Der Saag, P. T., Van Der Burg, B., and Gustafsson, J.-A. k. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252–4263.
| Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β.Crossref | GoogleScholarGoogle Scholar | 9751507PubMed |

Leiherer, A., Stoemmer, K., Muendlein, A., Saely, C. H., Kinz, E., Brandtner, E. M., Fraunberger, P., and Drexel, H. (2016). Quercetin impacts expression of metabolism-and obesity-associated genes in SGBS adipocytes. Nutrients 8, 282.
| Quercetin impacts expression of metabolism-and obesity-associated genes in SGBS adipocytes.Crossref | GoogleScholarGoogle Scholar |

Li, Q.-C., Wang, H.-Y., Chen, X., Guan, H.-Z., and Jiang, Z.-Y. (2010). Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul. Pept. 159, 72–77.
| Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans.Crossref | GoogleScholarGoogle Scholar | 19896982PubMed |

Mannerås-Holm, L., Leonhardt, H., Kullberg, J., Jennische, E., Odén, A., Holm, G., Hellström, M., Lönn, L., Olivecrona, G., and Stener-Victorin, E. (2011). Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J. Clin. Endocrinol. Metab. 96, E304–E311.
| Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.Crossref | GoogleScholarGoogle Scholar | 21084397PubMed |

Medjakovic, S., Mueller, M., and Jungbauer, A. (2010). Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR. Nutrients 2, 241–279.
| Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR.Crossref | GoogleScholarGoogle Scholar | 22254019PubMed |

Miksicek, R. J. (1994). Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49, 153–160.
| Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor.Crossref | GoogleScholarGoogle Scholar | 8031711PubMed |

Misugi, T., Ozaki, K., El Beltagy, K., Tokuyama, O., Honda, K., and Ishiko, O. (2006). Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats. Gynecol. Obstet. Invest. 61, 208–215.
| Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats.Crossref | GoogleScholarGoogle Scholar | 16479139PubMed |

Mostafavi–Pour, Z., Zal, F., Monabati, A., and Vessal, M. (2008). Protective effects of a combination of quercetin and vitamin E against cyclosporine A‐induced oxidative stress and hepatotoxicity in rats. Hepatol. Res. 38, 385–392.
| Protective effects of a combination of quercetin and vitamin E against cyclosporine A‐induced oxidative stress and hepatotoxicity in rats.Crossref | GoogleScholarGoogle Scholar | 17927767PubMed |

Mostafavi-Pour, Z., Khademi, F., Zal, F., Sardarian, A. R., and Amini, F. (2013). In vitro analysis of CsA-induced hepatotoxicity in HepG2 cell line: oxidative stress and α2 and β1 integrin subunits expression. Hepat. Mon. 13, e11447.
| In vitro analysis of CsA-induced hepatotoxicity in HepG2 cell line: oxidative stress and α2 and β1 integrin subunits expression.Crossref | GoogleScholarGoogle Scholar | 24082890PubMed |

Murakami, A., Ashida, H., and Terao, J. (2008). Multitargeted cancer prevention by quercetin. Cancer Lett. 269, 315–325.
| Multitargeted cancer prevention by quercetin.Crossref | GoogleScholarGoogle Scholar | 18467024PubMed |

Neisy, A., Zal, F., Seghatoleslam, A., and Alaee, S. (2019). Amelioration by quercetin of insulin resistance and uterine GLUT4 and ERα gene expression in rats with polycystic ovary syndrome (PCOS). Reprod. Fertil. Dev. 31, 315–323.
| Amelioration by quercetin of insulin resistance and uterine GLUT4 and ERα gene expression in rats with polycystic ovary syndrome (PCOS).Crossref | GoogleScholarGoogle Scholar | 30103849PubMed |

Panidis, D., Kourtis, A., Farmakiotis, D., Mouslech, T., Rousso, D., and Koliakos, G. (2003). Serum adiponectin levels in women with polycystic ovary syndrome. Hum. Reprod. 18, 1790–1796.
| Serum adiponectin levels in women with polycystic ovary syndrome.Crossref | GoogleScholarGoogle Scholar | 12923129PubMed |

Papalou, O., Livadas, S., Karachalios, A., Tolia, N., Kokkoris, P., Tripolitakis, K., and Diamanti-Kandarakis, E. (2015). White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia. Hormones (Athens) 14, 91–100.
| 25553762PubMed |

Patel, S. (2017). Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review. J. Steroid Biochem. Mol. Biol. 168, 19–25.
| Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review.Crossref | GoogleScholarGoogle Scholar | 28109841PubMed |

Rezvan, N., Moini, A., Janani, L., Mohammad, K., Saedisomeolia, A., Nourbakhsh, M., Gorgani-Firuzjaee, S., Mazaherioun, M., and Hosseinzadeh-Attar, M. J. (2017). Effects of quercetin on adiponectin-mediated insulin sensitivity in polycystic ovary syndrome: a randomized placebo-controlled double-blind clinical trial. Horm. Metab. Res. 49, 115–121.
| 27824398PubMed |

Rosenberg Zand, R. S. R., Jenkins, D. J., and Diamandis, E. P. (2002). Flavonoids and steroid hormone-dependent cancers. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 777, 219–232.
| Flavonoids and steroid hormone-dependent cancers.Crossref | GoogleScholarGoogle Scholar |

Santi, A., Baldissareli, J., Murussi, C. R., Dias, G. R., de Menezes, C. C., Zanini, D., Abdalla, F. H., Thome, G. R., Martins, C. C., Schetinger, M. R., and Loro, V. L. (2014). Effects of quercetin on oxidative stress biomarkers in methimazole-induced hypothyroid rats. Exp. Clin. Endocrinol. Diabetes 122, 533–539.
| Effects of quercetin on oxidative stress biomarkers in methimazole-induced hypothyroid rats.Crossref | GoogleScholarGoogle Scholar | 24918533PubMed |

Santini, S. E., Basini, G., Bussolati, S., and Grasselli, F. (2009). The phytoestrogen quercetin impairs steroidogenesis and angiogenesis in swine granulosa cells in vitro. J. Biomed. Biotechnol. 2009, 419891.
| The phytoestrogen quercetin impairs steroidogenesis and angiogenesis in swine granulosa cells in vitro.Crossref | GoogleScholarGoogle Scholar | 19704917PubMed |

Singh, A., Bora, P., and Krishna, A. (2017). Direct action of adiponectin ameliorates increased androgen synthesis and reduces insulin receptor expression in the polycystic ovary. Biochem. Biophys. Res. Commun. 488, 509–515.
| Direct action of adiponectin ameliorates increased androgen synthesis and reduces insulin receptor expression in the polycystic ovary.Crossref | GoogleScholarGoogle Scholar | 28522293PubMed |

Szmuilowicz, E. D., Stuenkel, C. A., and Seely, E. W. (2009). Influence of menopause on diabetes and diabetes risk. Nat. Rev. Endocrinol. 5, 553–558.
| Influence of menopause on diabetes and diabetes risk.Crossref | GoogleScholarGoogle Scholar | 19687788PubMed |

Tabandeh, M. R., Hosseini, A., Saeb, M., Kafi, M., and Saeb, S. (2010). Changes in the gene expression of adiponectin and adiponectin receptors (AdipoR1 and AdipoR2) in ovarian follicular cells of dairy cow at different stages of development. Theriogenology 73, 659–669.
| Changes in the gene expression of adiponectin and adiponectin receptors (AdipoR1 and AdipoR2) in ovarian follicular cells of dairy cow at different stages of development.Crossref | GoogleScholarGoogle Scholar | 20047754PubMed |

Thadhani, R., Wolf, M., Hsu-Blatman, K., Sandler, L., Nathan, D., and Ecker, J. L. (2003). First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. Am. J. Obstet. Gynecol. 189, 171–176.
| First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus.Crossref | GoogleScholarGoogle Scholar | 12861158PubMed |

Trikudanathan, S. (2015). Polycystic ovarian syndrome. Med. Clin. (North Am.) 99, 221–235.

Ververidis, F., Trantas, E., Douglas, C., Vollmer, G., Kretzschmar, G., and Panopoulos, N. (2007). Biotechnology of flavonoids and other phenylpropanoid‐derived natural products. Part I: chemical diversity, impacts on plant biology and human health. Biotechnol. J. 2, 1214–1234.
| Biotechnology of flavonoids and other phenylpropanoid‐derived natural products. Part I: chemical diversity, impacts on plant biology and human health.Crossref | GoogleScholarGoogle Scholar | 17935117PubMed |

Vessal, M., Hemmati, M., and Vasei, M. (2003). Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 135, 357–364.
| Antidiabetic effects of quercetin in streptozocin-induced diabetic rats.Crossref | GoogleScholarGoogle Scholar |

Vessal, M., Fathi, N., and Khoushdel, Z. (2004). Effect of aqueous extract of Physalis alkekengi fruits on the activity of ovarian 3beta-and 20alpha-hydroxysteroid dehydrogenases in late pregnancy in rat. Iran. J. Med. Sci. 29, 175–179.

Wang, Z., Zhai, D., Zhang, D., Bai, L., Yao, R., Yu, J., Cheng, W., and Yu, C. (2017). Quercetin decreases insulin resistance in a rat model by improving inflammatory microenvironment. Reprod. Sci. 24, 682–690.
| Quercetin decreases insulin resistance in a rat model by improving inflammatory microenvironment.Crossref | GoogleScholarGoogle Scholar | 27634381PubMed |

Wein, S., Behm, N., Petersen, R. K., Kristiansen, K., and Wolffram, S. (2010). Quercetin enhances adiponectin secretion by a PPAR-γ independent mechanism. Eur. J. Pharm. Sci. 41, 16–22.
| Quercetin enhances adiponectin secretion by a PPAR-γ independent mechanism.Crossref | GoogleScholarGoogle Scholar | 20580672PubMed |

Whitehead, S. A., and Lacey, M. (2003). Phytoestrogens inhibit aromatase but not 17β‐hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa‐luteal cells: evidence for FSH induction of 17β‐HSD. Hum. Reprod. 18, 487–494.
| Phytoestrogens inhibit aromatase but not 17β‐hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa‐luteal cells: evidence for FSH induction of 17β‐HSD.Crossref | GoogleScholarGoogle Scholar | 12615812PubMed |

Xu, Y., Zhang, H., Li, Q., Lao, K., and Wang, Y. (2017). The role of nesfatin-1 expression in letrozole-induced polycystic ovaries in the rat. Gynecol. Endocrinol. 33, 438–441.
| The role of nesfatin-1 expression in letrozole-induced polycystic ovaries in the rat.Crossref | GoogleScholarGoogle Scholar | 28277136PubMed |

Yamauchi, T., and Kadowaki, T. (2013). Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab. 17, 185–196.
| Adiponectin receptor as a key player in healthy longevity and obesity-related diseases.Crossref | GoogleScholarGoogle Scholar | 23352188PubMed |

Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., and Kubota, T. (2007). Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332–339.
| Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.Crossref | GoogleScholarGoogle Scholar | 17268472PubMed |

Yang, M., Zhang, Z., Wang, C., Li, K., Li, S., Boden, G., Li, L., and Yang, G. (2012). Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance. Diabetes 61, 1959–1968.
| Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance.Crossref | GoogleScholarGoogle Scholar | 22688332PubMed |

Yarahmadi, A., Zal, F., and Bolouki, A. (2017). Protective effects of quercetin on nicotine induced oxidative stress in ‘HepG2 cells’. Toxicol. Mech. Methods 27, 609–614.
| Protective effects of quercetin on nicotine induced oxidative stress in ‘HepG2 cells’.Crossref | GoogleScholarGoogle Scholar | 28627253PubMed |

Yarahmadi, A., Khademi, F., Mostafavi-Pour, Z., and Zal, F. (2018). In-vitro analysis of glucose and quercetin effects on m-TOR and Nrf-2 expression in HepG2 cell line (diabetes and cancer connection). Nutr. Cancer 70, 770–775.
| In-vitro analysis of glucose and quercetin effects on m-TOR and Nrf-2 expression in HepG2 cell line (diabetes and cancer connection).Crossref | GoogleScholarGoogle Scholar | 29781726PubMed |

Yen, S. S. C., Tsai, C. C., and Vela, P. (1971). Gestational diabetogenesis: quantitative analyses of glucose-insulin interrelationship between normal pregnancy and pregnancy with gestational diabetes. Am. J. Obstet. Gynecol. 111, 792–800.
| Gestational diabetogenesis: quantitative analyses of glucose-insulin interrelationship between normal pregnancy and pregnancy with gestational diabetes.Crossref | GoogleScholarGoogle Scholar |

Zhang, Z., Li, L., Yang, M., Liu, H., Boden, G., and Yang, G. (2012). Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 120, 91–95.
| Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus.Crossref | GoogleScholarGoogle Scholar | 22020667PubMed |

Ziamajidi, N., Behrouj, H., Abbasalipourkabir, R., and Lotfi, F. (2018). Ameliorative effects of Allium sativum extract on iNOS gene expression and NO production in liver of streptozotocin+ nicotinamide-induced diabetic rats. Indian J. Clin. Biochem. 33, 147–153.
| Ameliorative effects of Allium sativum extract on iNOS gene expression and NO production in liver of streptozotocin+ nicotinamide-induced diabetic rats.Crossref | GoogleScholarGoogle Scholar | 29651204PubMed |